{
  "doc_id": "5b84b472f8f855e4c510c7ee874bbc73d75984ba76cde2c4f99bd05c36dbbb11",
  "chunk_entities": [
    {
      "chunk_id": "bcd19bffd9b31efb17410d9ab6a98f0d",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "S. tortuosum",
          "context": "milled S. tortuosum raw material"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant activity",
          "context": "antidepressant and anxiolytic activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic activity",
          "context": "antidepressant and anxiolytic activity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depression",
          "context": "suffering from major depression"
        }
      ]
    },
    {
      "chunk_id": "79859a5283190f5c39c0f45bddac6d45",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "blockade of the serotonin (5-HT) transporter"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "blockade of the serotonin (5-HT) transporter"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4",
          "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT reuptake inhibitors",
          "context": "5-HT reuptake inhibitors (SSRIs) are widely used"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "5-HT reuptake inhibitors (SSRIs) are widely used"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitor",
          "context": "combination of SSRIs with a PDE4 inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "can upregulate PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "reduces the sensitivity to SSRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "dual treatment with SSRIs and PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "dual treatment with SSRIs and PDE4 inhibitors"
        },
        {
          "entity_type": "Plant",
          "entity_name": "S. tortuosum",
          "context": "extract of S. tortuosum (Zembrin)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "blockade of the serotonin (5-HT) transporter",
          "context": "comprising blockade of the serotonin (5-HT) transporter"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective inhibition of the phosphodiesterase-4 (PDE4) enzyme",
          "context": "selective inhibition of the phosphodiesterase-4 (PDE4) enzyme"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synergistic therapeutic potential",
          "context": "synergistic therapeutic potential in CNS disorders"
        },
        {
          "entity_type": "Effect",
          "entity_name": "greater symptomatic efficacy",
          "context": "providing greater symptomatic efficacy"
        },
        {
          "entity_type": "Effect",
          "entity_name": "broader therapeutic utility",
          "context": "broader therapeutic utility than either as a drug"
        },
        {
          "entity_type": "Effect",
          "entity_name": "upregulate PDE4",
          "context": "can upregulate PDE4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduces the sensitivity to SSRIs",
          "context": "reduces the sensitivity to SSRIs"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety disorders",
          "context": "treatment of anxiety disorders and depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "treatment of anxiety disorders and depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "CNS disorders",
          "context": "therapeutic potential in CNS disorders"
        }
      ]
    },
    {
      "chunk_id": "4fef5ab7d8ba792595e86a69f7ddb62f",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "purified water",
          "context": "purified water 30% V/V"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ethanol",
          "context": "ethanol 70% V/V"
        },
        {
          "entity_type": "Compound",
          "entity_name": "maltodextrin",
          "context": "maltodextrin carrier"
        },
        {
          "entity_type": "Plant",
          "entity_name": "S. tortuosum",
          "context": "South African plant S. tortuosum"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "four active alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenol",
          "context": "mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembranol",
          "context": "mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrine"
        }
      ]
    },
    {
      "chunk_id": "f146a09e48a40edc7b10ee3d64318dcd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "25 mg of Zembrin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "inert excipients",
          "context": "together with inert excipients"
        },
        {
          "entity_type": "Compound",
          "entity_name": "inert excipients",
          "context": "contained only inert excipients"
        },
        {
          "entity_type": "Plant",
          "entity_name": "S. tortuosum",
          "context": "above-ground S. tortuosum plant material"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "25 mg of Zembrin",
          "context": "contained 25 mg of Zembrin"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "50 mg of dry raw above-ground S. tortuosum plant material",
          "context": "equivalent to 50 mg of dry raw above-ground S. tortuosum plant material"
        }
      ]
    },
    {
      "chunk_id": "932f5c545e6c8ab8ffc64ff066df0d5d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "scanned once after Zembrin"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mood changes",
          "context": "report any mood changes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "side effects",
          "context": "or side effects"
        }
      ]
    },
    {
      "chunk_id": "c34aef509de734bc270ac325d1be1991",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone, Mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Chemical structures of four mesembrine alkaloids: Mesembrenol, Mesembrenone, Mesembrine, and Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine alkaloids",
          "context": "four mesembrine alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "1,2,3,4-tetrahydroisoquinoline core",
          "context": "a 1,2,3,4-tetrahydroisoquinoline core"
        },
        {
          "entity_type": "Compound",
          "entity_name": "3,4-dimethoxyphenyl group",
          "context": "a 3,4-dimethoxyphenyl group at the 1-position"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "Mesembrenol has a hydroxyl group at the 2-position"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ketone group",
          "context": "Mesembrenone has a ketone group at the 2-position"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methyl group",
          "context": "Mesembrine has a methyl group at the 2-position"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "Mesembranol has a hydroxyl group at the 2-position"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methyl group",
          "context": "Mesembranol has a hydroxyl group at the 2-position and a methyl group at the 3-position"
        }
      ]
    },
    {
      "chunk_id": "fb60c9c0b70713103205f79e07c7af06",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "DRUG (Zembrin versus placebo)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "DRUG (Zembrin versus placebo)"
        }
      ]
    },
    {
      "chunk_id": "0e7802a533907fb4715b29659d80c8cd",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-related",
          "context": "anxiety-related amygdala reactivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety-related amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "DRUG effects",
          "context": "test for DRUG effects"
        }
      ]
    },
    {
      "chunk_id": "e003158b77036d01f3aae2bd3f143b75",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "For High Load, both Zembrin and Placebo show high error rates"
        }
      ]
    },
    {
      "chunk_id": "413116c0769258ce05bddb71240cb603",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "compared with placebo"
        }
      ]
    },
    {
      "chunk_id": "57e11667ffaf4c2e7d9e67526c27cf87",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "after Zembrin compared with placebo administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "compared with placebo administration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreased functional connectivity",
          "context": "the amygdala showed overall decreased functional connectivity with the hypothalamus"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced amygdala\u2013hypothalamus connectivity",
          "context": "the reduced amygdala\u2013hypothalamus connectivity was marginally larger"
        }
      ]
    },
    {
      "chunk_id": "656e73965f25e14ad688fa3ff6a9a51a",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "single administration of Zembrin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "dual PDE4 and 5-HT reuptake inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "dual PDE4 and 5-HT reuptake inhibitor"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "S. tortuosum extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dual PDE4 and 5-HT reuptake inhibitor",
          "context": "characterized as a dual PDE4 and 5-HT reuptake inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "Zembrin compared with placebo administration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduces anxiety-related amygdala reactivity",
          "context": "reduces anxiety-related amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuates amygdala\u2013hypothalamus coupling",
          "context": "attenuates amygdala\u2013hypothalamus coupling"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety-related amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dampening effects",
          "context": "dampening effects of Zembrin"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety disorders",
          "context": "treatment of anxiety disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "treatment of anxiety disorders and depression"
        }
      ]
    },
    {
      "chunk_id": "c076a9c64f24a2a0fa881de9a0ff87cc",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "Anxiety",
          "context": "Anxiety is characterized by hyper-responsivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxious",
          "context": "clinically anxious individuals"
        },
        {
          "entity_type": "Disease",
          "entity_name": "state anxiety",
          "context": "increased by state anxiety"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "anxiolytic properties of S. tortuosum"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "anxiolytic properties of S. tortuosum"
        },
        {
          "entity_type": "Disease",
          "entity_name": "state anxiety",
          "context": "independent from state anxiety"
        }
      ]
    },
    {
      "chunk_id": "14f935f8e751d315efb905b37a223740",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Attenuation of threat responsivity",
          "context": "Attenuation of threat responsivity, as measured with the BOLD signal"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "after Zembrin administration"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety-related behaviors",
          "context": "involved in anxiety-related behaviors"
        }
      ]
    },
    {
      "chunk_id": "4544b3c0457a9a53dc094ea36a34fdc4",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "anxiolytic actions"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "actions of Zembrin"
        }
      ]
    },
    {
      "chunk_id": "51a599c1831b3ac45f6c742e3d0a2cb4",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic potential",
          "context": "support for the anxiolytic potential"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT reuptake inhibitors",
          "context": "dual 5-HT reuptake and PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "dual 5-HT reuptake and PDE4 inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synergistic potential",
          "context": "have synergistic potential"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "treatment of anxiety and depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "treatment of anxiety and depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduce side effects",
          "context": "used to reduce side effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRI",
          "context": "Acute SSRI administration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increase amygdala reactivity",
          "context": "increase amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduces amygdala reactivity",
          "context": "generally reduces amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased agitation",
          "context": "effect of increased agitation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased sensitivity for social information",
          "context": "increased sensitivity for social information"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "after first use of SSRIs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic properties",
          "context": "anxiolytic properties of SSRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "anxiolytic properties of SSRIs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduction of amygdala reactivity",
          "context": "the reduction of amygdala reactivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "state anxiety",
          "context": "linked to state anxiety"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "long-term Zembrin administration"
        }
      ]
    },
    {
      "chunk_id": "4853c671e27e4969aa77e0ea192a0118",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "inhibitor Zembrin reduces"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "dual 5-HT reuptake"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "and PDE4 inhibitor"
        },
        {
          "entity_type": "Disease",
          "entity_name": "fear",
          "context": "unattended facial fear"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "potential anxiolytic actions"
        }
      ]
    },
    {
      "chunk_id": "80aa3045640a2a8e39d0cec4d575193a",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "extract of Sceletium tortuosum (Zembrin)"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Zembrin",
          "context": "extract of Sceletium tortuosum (Zembrin)"
        }
      ]
    },
    {
      "chunk_id": "514fc4680f52d6651e526d3854f60fdd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "Assessing human 5-HT function"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "attentional bias in anxious and nonanxious individuals"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT",
          "context": "Acute 5-HT reuptake blockade"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reuptake blockade",
          "context": "Acute 5-HT reuptake blockade potentiates"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "effects of anxiety are gated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 inhibitor",
          "context": "by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline"
        },
        {
          "entity_type": "Compound",
          "entity_name": "6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline",
          "context": "inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "inhibition of serotonin re-uptake"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase",
          "context": "and phosphodiesterase by dual inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition",
          "context": "Stereoselective inhibition of serotonin re-uptake"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "agents for depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cyclic AMP phosphodiesterases",
          "context": "Cyclic AMP phosphodiesterases are localized"
        },
        {
          "entity_type": "Compound",
          "entity_name": "citalopram",
          "context": "effect of citalopram pretreatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "and antidepressant treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin 1A receptor",
          "context": "Medial prefrontal cortex serotonin 1A and 2A receptor binding"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin 2A receptor",
          "context": "serotonin 1A and 2A receptor binding"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Anxiety Disorder",
          "context": "Biol Mood Anxiety Disord"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-phosphodiesterase inhibitor",
          "context": "new cAMP-phosphodiesterase inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "inhibitor rolipram in patients"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depressive disorder",
          "context": "with major depressive disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "social anxiety disorder",
          "context": "Neuroimaging in social anxiety disorder"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase type IV",
          "context": "brain phosphodiesterase type IV measured"
        },
        {
          "entity_type": "Compound",
          "entity_name": "11C-(R)-rolipram",
          "context": "measured with 11C-(R)-rolipram positron emission tomography"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depressive disorder",
          "context": "in major depressive disorder"
        },
        {
          "entity_type": "Plant",
          "entity_name": "South African medicinal plants",
          "context": "selected South African medicinal plants"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium\u2014a review update"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE inhibitors",
          "context": "PDE inhibitors in psychiatry"
        },
        {
          "entity_type": "Disease",
          "entity_name": "dementia",
          "context": "options for dementia, depression and schizophrenia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "dementia, depression and schizophrenia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "schizophrenia",
          "context": "depression and schizophrenia"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Serotonin transporter",
          "context": "Serotonin transporter genetic variation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressants",
          "context": "Why do antidepressants take so long to work?"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "model of antidepressant drug action"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "food plant Sceletium tortuosum and its principal alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "and its principal alkaloids"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "to pathological anxiety"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Oxytocin",
          "context": "Oxytocin modulates neural circuitry"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP-phosphodiesterase-4",
          "context": "Cortico-striatal cyclic AMP-phosphodiesterase-4 signalling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "after chronic fluoxetine treatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant-like effects",
          "context": "Antidepressant- and anxiolytic-like effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic-like effects",
          "context": "Antidepressant- and anxiolytic-like effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 inhibitor",
          "context": "of the phosphodiesterase-4 inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "inhibitor rolipram on behavior"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP response element binding protein",
          "context": "depend on cyclic AMP response element binding protein-mediated neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant medications",
          "context": "Antidepressant medications reduce subcortical-cortical"
        },
        {
          "entity_type": "Compound",
          "entity_name": "citalopram",
          "context": "single dose of citalopram"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "single dose",
          "context": "Effect of a single dose of citalopram"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "extract Sceletium tortuosum (Zembrin\u00ae)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "Sceletium tortuosum (Zembrin\u00ae) in healthy adults"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "Association study of PDE4B with panic disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "panic disorder",
          "context": "with panic disorder in the Japanese population"
        },
        {
          "entity_type": "Plant",
          "entity_name": "South African Indigenous Plants",
          "context": "South African Indigenous Plants used as Remedies"
        }
      ]
    },
    {
      "chunk_id": "105aa650773263823b523f15c885acb0",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase type 4 isozymes",
          "context": "Phosphodiesterase type 4 isozymes expression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "[3H]rolipram",
          "context": "[3H]rolipram binding autoradiography"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant drug action",
          "context": "antidepressant drug action"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "nausea produced by rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 (PDE4) inhibitor",
          "context": "rolipram, a phosphodiesterase-4 (PDE4) inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "nausea",
          "context": "detect nausea produced by rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase inhibitors",
          "context": "Phosphodiesterase inhibitors enhance object memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhance object memory",
          "context": "Phosphodiesterase inhibitors enhance object memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Calcium-independent phosphodiesterase inhibitors",
          "context": "Calcium-independent phosphodiesterase inhibitors as putative antidepressants"
        },
        {
          "entity_type": "Effect",
          "entity_name": "putative antidepressants",
          "context": "inhibitors as putative antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "[3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones",
          "context": "[3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones"
        },
        {
          "entity_type": "Disease",
          "entity_name": "DSM-IV",
          "context": "diagnostic psychiatric interview for DSM-IV"
        },
        {
          "entity_type": "Disease",
          "entity_name": "ICD-10",
          "context": "diagnostic psychiatric interview for DSM-IV and ICD-10"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "effects of Sceletium tortuosum"
        },
        {
          "entity_type": "Disease",
          "entity_name": "psychological stress",
          "context": "model of psychological stress"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Psychoactive",
          "context": "Psychoactive constituents of the genus Sceletium"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "constituents of the genus Sceletium N.E.Br."
        },
        {
          "entity_type": "Plant",
          "entity_name": "Mesembryanthemaceae",
          "context": "other Mesembryanthemaceae"
        },
        {
          "entity_type": "Disease",
          "entity_name": "basolateral amygdala damage",
          "context": "after basolateral amygdala damage"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Testosterone",
          "context": "Testosterone reduces amygdala-orbitofrontal cortex coupling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduces amygdala-orbitofrontal cortex coupling",
          "context": "Testosterone reduces amygdala-orbitofrontal cortex coupling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Progesterone",
          "context": "Progesterone selectively increases amygdala reactivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases amygdala reactivity",
          "context": "Progesterone selectively increases amygdala reactivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "fear",
          "context": "amygdala in fear"
        },
        {
          "entity_type": "Disease",
          "entity_name": "stress",
          "context": "amygdala in fear, stress"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "stress, and anxiety"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase type 4 inhibitor rolipram",
          "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases recognition memory persistence",
          "context": "increases recognition memory persistence"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant treatment",
          "context": "repeated antidepressant treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type 4A phosphodiesterase (PDE4A)",
          "context": "treatment of type 4A phosphodiesterase (PDE4A)"
        }
      ]
    }
  ],
  "total_entities": 197,
  "extraction_date": "2026-02-01T08:28:05.427112+00:00"
}